相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Targeting epigenetic enzymes for drug discovery
Robert A. Copeland et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2010)
Deregulation of H3K27 methylation in cancer
Eva Martinez-Garcia et al.
NATURE GENETICS (2010)
Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin
Ryan D. Morin et al.
NATURE GENETICS (2010)
Structural Biology of Human H3K9 Methyltransferases
Hong Wu et al.
PLOS ONE (2010)
New insights into the biology and origin of mature aggressive B-cell lymphomas by combined epigenomic, genomic, and transcriptional profiling
Jose I. Martin-Subero et al.
BLOOD (2009)
Chromatin Signatures in Multipotent Human Hematopoietic Stem Cells Indicate the Fate of Bivalent Genes during Differentiation
Kairong Cui et al.
CELL STEM CELL (2009)
Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer
Gijs van Haaften et al.
NATURE GENETICS (2009)
Protein methyltransferases as a target class for drug discovery
Robert A. Copeland et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Ezh2 requires PHF1 to efficiently catalyze h3 lysine 27 trimethylation in vivo
Kavitha Sarma et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
EZH1 Mediates Methylation on Histone H3 Lysine 27 and Complements EZH2 in Maintaining Stem Cell Identity and Executing Pluripotency
Xiaohua Shen et al.
MOLECULAR CELL (2008)
Roles of the EZH2 histone methyltransferase in cancer epigenetics
Jeffrey A. Simon et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2008)
Enzymatic mechanism and product specificity of SET-domain protein lysine methyltransferases
Xiaodong Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Role of hPHF1 in H3K27 methylation and Hox gene silencing
Ru Cao et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
High-resolution profiling of histone methylations in the human genome
Artern Barski et al.
CELL (2007)
Connections between epigenetic gene silencing and human disease
Timothy J. Moss et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2007)
A bivalent chromatin structure marks key developmental genes in embryonic stem cells
BE Bernstein et al.
CELL (2006)
The SET-domain protein superfamily: protein lysine methyltransferases
SC Dillon et al.
GENOME BIOLOGY (2005)
SUZ12 is required for both the histone methyltransferase activity and the silencing function of the EED-EZH2 complex
R Cao et al.
MOLECULAR CELL (2004)
In vivo labeling of fission yeast DNA with thymidine and thymidine analogs
S Sivakumar et al.
METHODS (2004)
Silencing of human polycomb target genes is associated with methylation of histone H3 Lys 27
A Kirmizis et al.
GENES & DEVELOPMENT (2004)
EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer
AP Bracken et al.
EMBO JOURNAL (2003)
EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells
CG Kleer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Structure and catalytic mechanism of the human histone methyltransferase SET7/9
B Xiao et al.
NATURE (2003)
The polycomb group protein EZH2 is involved in progression of prostate cancer
S Varambally et al.
NATURE (2002)
Coexpression of BMI-1 and EZH2 polycomb-group proteins is associated with cycling cells and degree of malignancy in B-cell non-Hodgkin lymphoma
FJ van Kemenade et al.
BLOOD (2001)